A detailed history of Franklin Resources Inc transactions in Cassava Sciences Inc stock. As of the latest transaction made, Franklin Resources Inc holds 21,878 shares of SAVA stock, worth $589,612. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,878
Previous 19,144 14.28%
Holding current value
$589,612
Previous $388,000 30.41%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$12.35 - $26.11 $33,764 - $71,384
2,734 Added 14.28%
21,878 $270,000
Q1 2024

May 13, 2024

SELL
$18.44 - $26.41 $497 - $713
-27 Reduced 0.14%
19,144 $388,000
Q4 2023

Feb 09, 2024

BUY
$12.64 - $30.11 $242,321 - $577,238
19,171 New
19,171 $431,000
Q2 2023

Aug 11, 2023

BUY
$21.59 - $27.88 $181,528 - $234,415
8,408 New
8,408 $206,000

Others Institutions Holding SAVA

About CASSAVA SCIENCES INC


  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $1.08B
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.